MedPath

Total Knee Replacement With the Attune vs. the Press Fit Condylar (PFC) Sigma.

Not Applicable
Conditions
Osteoarthrosis, Knee
Registration Number
NCT03077958
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Brief Summary

100 knees with primary osteoarthritis and scheduled for a total knee replacement (TKR) will be recruited from our waiting list. The patients will be randomized to become operated with the Attune or PFC total knee arthroplasty. Randomisation will be done using envelopes. Patients can only participate with one knee.

Detailed Description

The Attune total knee replacement is a recently developed implant with the intention to improve the outcome after this procedure. One of the primary aims is to improve the kinematics of the knee in order to more closely mimic the normal knee. Thereby the patients are expected to experience improved function, better stability and less pain during activity. So far there are no randomized studies which have demonstrated this potential superior performance when compared to its predecessor, the PFC Sigma TKR. This study aims to evaluate the clinical outcome and the knee kinematics of the Attune knee using recognized clinical outcome parameters and dynamic radiostereometry. The PFC sigma knee will be used as control.

100 knees with primary osteoarthritis and scheduled for a total knee replacement (TKR) will be recruited from our waiting list. The patients will be randomized to become operated with the Attune or PFC total knee arthroplasty. Randomization will be done using envelopes. Patients can only participate with one knee.

Surgical procedure: The operations will be done according to our routines without use of bloodless field. Local analgesia will be infiltrated periarticulary during the operation. Cemented fixation will be used in all cases. So-called "fast-track"principles will be applied in both Groups.

Patients will be followed for five years.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Medial or lateral primary osteoarthritis (OA) Ahlbäck Grade 2-4
  • Varus or valgus deformity ≤15 degrees, extension defect ≤15 degrees
  • BMI <35
  • ASA 1-3.
  • Coming from independent living in own home
  • Written informed consent
Exclusion Criteria
  • Cortisone treatment during the last 6 months before operation
  • Neurological diseases with symptoms, stroke with sequel
  • Endocrine diseases with symptoms
  • OA secondary to trauma, infection, inflammatory disease or congenital and acquired deformities
  • BMI >=35
  • OA of the hip with symptoms. (Patients operated with total hip arthroplasty are accepted)
  • Ongoing infection
  • Unable or unwilling to participate in the follow-up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Oxford Knee Score (OKS)Preoperatively to 2 years

The Oxford Knee Score (OKS) is a 12-item patient-reported outcome measure (PROM) specifically designed and developed to assess function and pain after total knee replacement (TKR) surgery (arthroplasty). It is short, reproducible, valid and sensitive to clinically important changes.

Secondary Outcome Measures
NameTimeMethod
Patient satisfaction is reported on a visual analogue scale (VAS) 1-10Preoperatively to 2 years

Patient satisfaction is reported on a visual analogue scale (VAS) 1-10

Pain (VAS)Preoperatively to 2 years

Patient pain reported on Visual Analogue Scales(VAS) 1-10

Knee Kinematics, (anterior-posterior translations and axial rotations)2 years

Dynamic radiostereometric analysis with detailed recordings of the threedimensional motions of the knee during a step-up

Trial Locations

Locations (1)

Department of Orthopaedics

🇸🇪

Molndal, Västra Götaland, Sweden

© Copyright 2025. All Rights Reserved by MedPath